The Uk Government has agreed a deal with Valneva which secures 40 million doses of the vaccine they are producing, once it is approved.
The vaccine which is manufactured in Scotland has reported promising data and results from trials, and this would be another vaccine to add to the increasing number available.
The UK now has early access to over 400 million total doses of vaccine for this year and next.
The UK Government invested multi-millions in the Valneva manufacturing facility in Livingston in Scotland, which has now started manufacturing vaccine doses. About 100 new highly-skilled jobs for scientists and technicians have been created.
The Medicines and Healthcare products Regulatory Agency (MHRA) will have to approve the vaccine before it is rolled out, possibly at the end of the year.
Business Secretary Kwasi Kwarteng said: “This latest deal is yet another weapon in our national arsenal against this terrible disease, and will ensure we have sufficient supplies to protect the British public in 2021 and beyond.
“Backed with major investment from the UK Government, Valneva’s site in Scotland will be a vaccine production powerhouse, working flat out to ensure we can quickly deploy jabs across the UK if their candidate is approved, while supporting top quality, local jobs.
“Thanks to our incredible UK Vaccine Taskforce, we have now secured a bumper portfolio of over 400 million vaccines, putting our country in an exceptionally strong position to defeat this virus once and for all.”
Health Secretary Matt Hancock said: “The UK has developed and invested in some of the world’s most promising vaccines – supporting global efforts to fight this virus.
“The Valneva vaccine showcases the best of Scottish expertise right at the heart of our UK vaccine endeavour, demonstrating the strength of our union and what the UK can achieve when it works together. If the vaccine is authorised by the health regulator, it will be rolled out across the four nations as quickly as possible.”